MoneyWorks4Me

The revenue zoomed 19.57% to Rs. 3816.00 millions for the quarter ended June 2026 as compared to Rs. 3191.50 millions during the corresponding quarter last year.Profit for the quarter ended June 2026 rises by 61.35% to Rs. 169.90  millions from Rs. 105.30 millions.OP of the company witnessed a marginal growth to 639.30 millions from 580.10 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3816.00 3191.50 19.57 3816.00 3191.50 19.57 13689.80 12837.60 6.64
Other Income 19.20 9.80 95.92 19.20 9.80 95.92 58.90 91.40 -35.56
PBIDT 639.30 580.10 10.21 639.30 580.10 10.21 1925.70 2129.80 -9.58
Interest 202.30 239.00 -15.36 202.30 239.00 -15.36 942.40 1148.10 -17.92
PBDT 437.00 341.10 28.11 437.00 341.10 28.11 924.40 981.70 -5.84
Depreciation 267.10 235.80 13.27 267.10 235.80 13.27 996.80 992.50 0.43
PBT 169.90 105.30 61.35 169.90 105.30 61.35 -72.40 -10.80 570.37
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 169.90 105.30 61.35 169.90 105.30 61.35 -72.40 -10.80 570.37
Equity 480.60 443.40 8.39 480.60 443.40 8.39 445.10 402.50 10.58
PBIDTM(%) 16.75 18.18 -7.83 16.75 18.18 -7.83 14.07 16.59 -15.21
Peers
Company Name CMP
Sun Pharma. Inds. 1848.60
Dr. Reddys Labs. 1200.40
Cipla 1412.25
Lupin 2086.20
Zydus Lifesciences 1192.00
View more..